These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37657737)

  • 1. Improved dyspeptic symptoms of type 1 diabetes adults with gastroparesis on hybrid closed loop system: A case series.
    Phan F; Halbron M; Jacqueminet S; Popelier M; Soliman H; Coffin B; Hartemann A; Amouyal C
    Diabetes Metab; 2023 Sep; 49(5):101471. PubMed ID: 37657737
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series.
    Daly A; Hartnell S; Boughton CK; Evans M
    J Diabetes Sci Technol; 2021 Nov; 15(6):1216-1223. PubMed ID: 34378426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Hybrid Closed-Loop System in Adults with Type 1 Diabetes and Gastroparesis.
    Kaur H; Schneider N; Pyle L; Campbell K; Akturk HK; Shah VN
    Diabetes Technol Ther; 2019 Dec; 21(12):736-739. PubMed ID: 31347928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced hybrid closed-loop use in children less than 2 years old with diluted insulin: a case series.
    Wanaguru A; Phan P; Lim L; Verge C; Hameed S; Neville K
    Acta Diabetol; 2024 Feb; 61(2):257-261. PubMed ID: 38097818
    [No Abstract]   [Full Text] [Related]  

  • 5. Cognitive function in T1DM improved by hybrid closed-loop insulin delivery.
    Tysoe O
    Nat Rev Endocrinol; 2022 Nov; 18(11):657. PubMed ID: 36085416
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.
    Thabit H; Boughton C; Mubita W; Rubio J; Mader JK; Narendran P; Evans M; Leelarathna L; Wilinska ME; Fullwood C; Gregory AM; Hovorka R; Rutter MK
    Diabetes Obes Metab; 2023 Mar; 25(3):889-893. PubMed ID: 36335565
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving HbA
    Jacobs PG
    Lancet Diabetes Endocrinol; 2022 Oct; 10(10):684-686. PubMed ID: 36058209
    [No Abstract]   [Full Text] [Related]  

  • 8. First Randomized Controlled Trial of Hybrid Closed Loop Versus Multiple Daily Injections or Insulin Pump Using Self-Monitoring of Blood Glucose in Free-Living Adults with Type 1 Diabetes Undertaking Exercise.
    Paldus B; Lee MH; Morrison D; Zaharieva DP; Jones H; Obeyesekere V; Lu J; Vogrin S; LaGerche A; McAuley SA; MacIsaac RJ; Jenkins AJ; Ward GM; Colman P; O'Neal DN
    J Diabetes Sci Technol; 2021 Nov; 15(6):1399-1401. PubMed ID: 34315271
    [No Abstract]   [Full Text] [Related]  

  • 9. Hope, hype and present limitations of hybrid closed loop systems for persons with type 1 diabetes.
    Thivolet C
    Diabetes Metab; 2024 Mar; 50(2):101510. PubMed ID: 38232814
    [No Abstract]   [Full Text] [Related]  

  • 10. Real world evidence of the efficacy of two hybrid closed loop systems for children and adults with type 1 diabetes with some clinical warnings.
    Henry Z; Villar Fimbel S; Bendelac N; Thivolet C
    Diabetes Metab; 2022 Nov; 48(6):101396. PubMed ID: 36252880
    [No Abstract]   [Full Text] [Related]  

  • 11. Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative.
    Noor N; Kamboj MK; Triolo T; Polsky S; McDonough RJ; Demeterco-Berggren C; Jacobsen L; Sonabend R; Ebekozien O; DeSalvo DJ
    Diabetes Care; 2022 Aug; 45(8):e118-e119. PubMed ID: 35708494
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of hybrid closed-loop insulin delivery on cardiac rhythm in older adults with type 1 diabetes: A post hoc analysis of trial data.
    Thabit H; Boughton C; Mubita W; Rubio J; Allen S; Heugh R; Mader JK; Narendran P; Evans M; Leelarathna L; Wilinska ME; Fullwood C; Garratt C; Hovorka R; Rutter MK
    Diabetes Obes Metab; 2024 Mar; 26(3):1105-1109. PubMed ID: 37984425
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe hypoglycemia caused by hydroxyurea interference on continuous glucose sensor integrated with advanced hybrid closed-loop system: a case report.
    Conti M; Meneghini E; Fumagalli G; Guidoni F; Bertuzzi F; Pintaudi B
    Acta Diabetol; 2023 Dec; 60(12):1749-1752. PubMed ID: 37561210
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Advanced Hybrid Closed-Loop System in a Patient with Pancreas Cancer.
    Hacisahinogullari H; Caklili OT; Saribeyliler G; Rasulova N; Selcukbiricik O; Gul N; Uzum AK; Karsidag K
    Diabetes Technol Ther; 2022 Sep; 24(9):675-676. PubMed ID: 35349364
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System.
    Dodesini AR; Borella ND; Lepore G; Bonfadini S; Corsi A; Scaranna C; Bellante R; Trevisan R
    Diabetes Technol Ther; 2023 Jul; 25(7):516-518. PubMed ID: 36930146
    [No Abstract]   [Full Text] [Related]  

  • 16. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful transitioning children and adolescents with type 1 diabetes from multiple daily injections to advanced hybrid closed-loop system in 10 days: a prospective intervention study on MiniMed 780G system.
    Petrovski G; Al Khalaf F; Campbell J; Day E; Almajaly D; Hussain K; Pasha M; Umer F; Hamdan M; Khalifa A
    Acta Diabetol; 2022 May; 59(5):743-746. PubMed ID: 35072781
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the Editor Regarding Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently-Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands.
    Levrat-Guillen F; De Cock P
    Adv Ther; 2023 May; 40(5):2542-2544. PubMed ID: 36892808
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of Real-life Usage of Advanced Hybrid Closed-Loop System MiniMed 780G in Children With Type 1 Diabetes Younger Than 7 Years Old.
    Tornese G; Carletti C; Lanzetta MA; Tamaro G; Barbi E; Faleschini E
    Diabetes Care; 2023 Jun; 46(6):e123-e125. PubMed ID: 37068287
    [No Abstract]   [Full Text] [Related]  

  • 20. Real world effectiveness of clinically approved hybrid closed loop systems in a UK Secondary Care Diabetes Service.
    Bashir B; Elisaus P; Grigoriadou VC; Urwin A; Chapman A; Ohol S; Findlow LA; Foster J; Harwood R; Fullwood C; Schofield J; Rutter MK; Leelarathna L; Thabit H
    Diabet Med; 2022 May; 39(5):e14816. PubMed ID: 35181937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.